Nanalysis Scientific Corp. (TSXV:NSCI) is looking for acquisitions. Sean Krakiwsky said, "As I sort of implied when I showed the full product portfolio, our revenue in that area is about $2 million trailing 12 months.

So a material amount, but it's not where the biggest part of our current revenue is. But going forward, our strategy will include acquisitions. We're working with a couple of companies right now on custom MRI projects.

And my plan is to acquire those companies that have experience in the FDA approval process, have great vision for exactly what type of applications, specific -- application-specific, meaning only the brain or only the torso or only the limb. And we're working with them on these projects right now".